National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 383928

History of Changes from the VAERS Wayback Machine

First Appeared on 4/7/2010

VAERS ID: 383928
VAERS Form:
Age:0.1
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (UNKNOWN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / WYETH PHARMACEUTICALS, INC D28551 / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 8/31/2010

VAERS ID: 383928 Before After
VAERS Form:
Age:0.1
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (UNKNOWN) DTAP+IPV+HEPB+HIB (NO BRAND NAME) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / WYETH PHARMACEUTICALS, INC PFIZER/WYETH D28551 / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 11/3/2010

VAERS ID: 383928 Before After
VAERS Form:
Age:0.1
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (NO BRAND NAME) DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 1/4/2011

VAERS ID: 383928 Before After
VAERS Form:
Age:0.1
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS (UNKNOWN) GLAXOSMITHKLINE BIOLOGICALS A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 5/13/2013

VAERS ID: 383928 Before After
VAERS Form:
Age:0.1
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UN / IM
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 2/14/2017

VAERS ID: 383928 Before After
VAERS Form:
Age:0.1 0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 5/14/2017

VAERS ID: 383928 Before After
VAERS Form:
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN) DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / - UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - - / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 9/14/2017

VAERS ID: 383928 Before After
VAERS Form:(blank) 1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / - UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / - UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / - UNK - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 2/14/2018

VAERS ID: 383928 Before After
VAERS Form:1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 6/14/2018

VAERS ID: 383928 Before After
VAERS Form:1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 8/14/2018

VAERS ID: 383928 Before After
VAERS Form:1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 9/14/2018

VAERS ID: 383928 Before After
VAERS Form:1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.


Changed on 10/14/2018

VAERS ID: 383928 Before After
VAERS Form:1
Age:0.14
Sex:Unknown
Location:Foreign
Vaccinated:2010-01-06
Onset:2010-01-11
Submitted:2010-03-31
Entered:2010-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS A20CA635A / UNK UN / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D28551 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA987A / UNK MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Abdominal rigidity, Blood culture, Body temperature decreased, Gastrointestinal disorder, Haematochezia, Hypotonic-hyporesponsive episode, Intussusception, Rash maculo-papular, Sepsis, Gastrointestinal hypomotility, Peritoneal disorder, Ultrasound scan abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 0     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Body temperature, 11Jan2010, 35.9deg. C
CDC 'Split Type': B0643201A

Write-up: This case was reported by a regulatory authority (PL-URPL-OCM-20100323027) and described the occurrence of suspected intussusception in a 9-week-old subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline), INFANRIX HEXA and PREVNAR (non-gsk). On 6 January 2010 the subject received unspecified dose of ROTARIX (oral), unspecified dose of INFANRIX HEXA (intramuscular, unknown), unspecified dose of PREVNAR (intramuscular, unknown). On 11 January 2010, 5 days after vaccination with INFANRIX HEXA, PREVNAR and ROTARIX, the subject experienced merging maculo-papular rash and hypotonic-hyporesponsive episode. Subsequently, the child was hospitalised. On admission, the child had decreased body temperature (35.9 deg. C). An ultrasonography showed dilated intestinal loops, intestinal hypomotility and traces of fluid in the peritoneum. The child was referred to the Infectious Disease Clinic because of suspected sepsis. During the first days of admission, the child was in a serious condition and experienced hematochezia, hard abdomen and intestinal hypomotility. No pathological flora was isolated from the blood culture. Because of the vaccination with ROTARIX, the possibility of spontaneously resolved intussusception was considered. The subject was hospitalised. At the time of reporting the events were improved. The regulatory Authority has provided GSK with all the available information at this time, any further information received by the regulatory authority will be forwarded to GSK.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=383928&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166